Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review

BACKGROUND: Antiangiogenic agents (AAs) are increasingly used to treat malignant tumors and have been associated with gastrointestinal (GI) bleeding and perforation. Elective surgeries and endoscopy are recommended to be delayed for 31 d until after AAs treatment. Data regarding the safety of endosc...

Descripción completa

Detalles Bibliográficos
Autores principales: Azam, Mohammad, Hudgi, Amit, Uy, Pearl Princess, Makhija, Jinal, Yap, John Erikson L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329849/
https://www.ncbi.nlm.nih.gov/pubmed/36051996
http://dx.doi.org/10.4253/wjge.v14.i7.416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329849/
https://www.ncbi.nlm.nih.gov/pubmed/36051996
http://dx.doi.org/10.4253/wjge.v14.i7.416

Ejemplares similares